abstract |
The present invention provides compounds of the formula (I) and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; And methods for their preparation, pharmaceutical compositions containing them and their use in therapy. The compound is an inhibitor of microsomal prostaglandin E synthase-1. <Formula I> Wherein R 1 , R 3 , L 1 , L 2 , G 1 , G 2 , A and m are as defined herein. |